Lincoln D. Nadauld, MD, PhD, is the medical director of cancer genomics at Intermountain Healthcare where he oversees the clinical implementation of genomic cancer medicine across Intermountain’s 22 hospitals and 180 physician clinics. Lincoln completed combined MD/PhD and clinical training at the University of Utah with his doctoral dissertation focused on the molecular genetics of colon cancer. He completed additional clinical training in medical oncology at Stanford University where he also completed a postdoctoral fellowship in solid tumor genomics in the laboratory of Dr. Calvin Kuo. Lincoln remains on faculty at the Stanford School of Medicine as a consulting assistant professor in the Division of Oncology.